Regulatory Affairs (RA) Training Course

This training introduces step-by-step processes involved in bringing a drug from laboratory stage to the market — including research, clinical trials, manufacturing compliance, labeling, import/export permissions, and post-marketing surveillance. Learners understand how regulatory agencies evaluate the safety, efficacy, and quality of pharmaceutical products before granting approval. Major guidelines including ICH, WHO, USFDA, EMA, MHRA, TGA, CDSCO, Health Canada, and ASEAN regulations are covered in a comparative and structured way to support global career opportunities.

Participants learn about Dossier Submission formats such as CTD (Common Technical Document) and eCTD (Electronic Common Technical Document), including Module 1 to Module 5 structure, granularity, publishing, and lifecycle management. The training also covers New Drug Applications (NDA), Abbreviated New Drug Applications (ANDA), Investigational New Drug (IND), Marketing Authorization Applications (MAA), and post-approval variations. Guidance is given on preparing regulatory dossiers for APIs, finished formulations, vaccines, and biologics.

The course explains how product approvals differ for generics, branded drugs, medical devices, cosmetics, and nutraceuticals. Learners will become familiar with classification systems such as USFDA device classes and EU Medical Device Regulation (MDR). Regulatory updates, pharmacovigilance requirements, clinical trial rules (ICH GCP), and risk-benefit evaluation are taught to ensure regulatory compliance throughout the product lifecycle.

A strong emphasis is placed on labeling, artwork, and packaging compliance, where trainees learn how essential product information such as storage conditions, safety warnings, dosage instructions, and serialization requirements are evaluated before release. Additionally, the course covers regulatory intelligence, submission tracking, query response writing, online portal usage, and communication with agencies to support fast approvals.

Learners are trained in DMF (Drug Master File) and registration of raw materials such as excipients and packaging components. They understand how site inspections are conducted by regulatory bodies such as USFDA, and how companies must maintain strong documentation to face audits confidently. Participants will also gain insights into GMP compliance (ICH Q7, Schedule M), technical documents, validation protocols, stability studies, and shelf-life assignment.

To build hands-on skills, real case studies and industry templates for product registration, variation filing, and regulatory updates are included. Learners will practice document writing, gap assessments, and regulatory review checkpoints used in global submissions. This course also introduces RA career pathways such as CMC regulatory writing, labeling specialist roles, clinical regulatory affairs, and post-approval lifecycle management.

Post marketing surveillance laws including pharmacovigilance reporting, product complaints, and recall management are explained. The training helps learners understand that Regulatory Affairs is a continuous responsibility even after the drug is approved. The ability to collaborate with multiple departments — R&D, QA, QC, Production, Packaging, Supply Chain, and Marketing — is developed through practical communication modules.

Overall, this course transforms participants into high-performing Regulatory Affairs professionals who can manage product approvals efficiently, maintain compliance with evolving rules, prevent regulatory risks, and contribute to global patient safety. It supports job readiness for RA roles in global and domestic markets covering human pharmaceuticals, biologics, veterinary medicines, medical devices, cosmetics, nutraceuticals, and FMCG industries. With this training, learners can confidently support regulatory documentation, communication, and compliance functions throughout the product lifecycle, making them valuable assets to any organization.